Author Affiliations: Center for Clinical Studies (Dr LaPolla) and Department of Dermatology, University of Texas Health Science Center (Dr Tyring), Houston.
We thank Dr Fett for her letter and agree that the best method to prevent PHN is to prevent herpes zoster. As she points out, however, only 7% of adults aged at least 60 years who are eligible for shingles vaccination have actually received the vaccine. Food and Drug Administration approval for the vaccination of adults aged 50 to 60 years was only recently granted; thus, the vaccination rate in this patient group is even lower, probably less than 1%. Therefore, we will continue to see patients with shingles, at risk for PHN, for many years to come.
LaPolla W, Tyring SK. Gabapentin Not Shown to Prevent Postherpetic Neuralgia —Reply. Arch Dermatol. 2012;148(3):401. doi:10.1001/archdermatol.2011.2867